Stealth BioTherapeutics Competitor Insights

Stealth BioTherapeutics is a biopharmaceutical company focused on developing therapies for mitochondrial dysfunction, a key factor in various rare and age-related diseases. They are conducting clinical trials for their lead candidate, elamipretide, which targets and improves mitochondrial function. Stealth BioTherapeutics aims to address the unmet medical needs of patients suffering from debilitating diseases by offering innovative treatment solutions.